
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy
Xiaoxue Xie, Yi Feng, Hanxi Zhang, et al.
Bioactive Materials (2022) Vol. 16, pp. 107-119
Open Access | Times Cited: 42
Xiaoxue Xie, Yi Feng, Hanxi Zhang, et al.
Bioactive Materials (2022) Vol. 16, pp. 107-119
Open Access | Times Cited: 42
Showing 1-25 of 42 citing articles:
Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 106
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 106
Current understanding of plant-derived exosome-like nanoparticles in regulating the inflammatory response and immune system microenvironment
Qiaoli Yi, Zhijie Xu, Abhimanyu Thakur, et al.
Pharmacological Research (2023) Vol. 190, pp. 106733-106733
Open Access | Times Cited: 87
Qiaoli Yi, Zhijie Xu, Abhimanyu Thakur, et al.
Pharmacological Research (2023) Vol. 190, pp. 106733-106733
Open Access | Times Cited: 87
Dendritic Nanomedicine with Boronate Bonds for Augmented Chemo‐Immunotherapy via Synergistic Modulation of Tumor Immune Microenvironment
Yunkun Li, Yahui Wu, Zaixiang Fang, et al.
Advanced Materials (2023) Vol. 36, Iss. 2
Closed Access | Times Cited: 44
Yunkun Li, Yahui Wu, Zaixiang Fang, et al.
Advanced Materials (2023) Vol. 36, Iss. 2
Closed Access | Times Cited: 44
CD8+ T cell-based cancer immunotherapy
Yanxia Chen, Dingning Yu, Hui Qian, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Yanxia Chen, Dingning Yu, Hui Qian, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Enhancing drug penetration in solid tumors via nanomedicine: Evaluation models, strategies and perspectives
Xiaoding Shen, Dayi Pan, Qiyong Gong, et al.
Bioactive Materials (2023) Vol. 32, pp. 445-472
Open Access | Times Cited: 40
Xiaoding Shen, Dayi Pan, Qiyong Gong, et al.
Bioactive Materials (2023) Vol. 32, pp. 445-472
Open Access | Times Cited: 40
Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy
Prashant Sharma, Mario Otto
Bioactive Materials (2023) Vol. 31, pp. 440-462
Open Access | Times Cited: 34
Prashant Sharma, Mario Otto
Bioactive Materials (2023) Vol. 31, pp. 440-462
Open Access | Times Cited: 34
NIR/pH-triggered aptamer-functionalized DNA origami nanovehicle for imaging-guided chemo-phototherapy
Mengyue Li, Geng Yang, Yue Zheng, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 28
Mengyue Li, Geng Yang, Yue Zheng, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 28
Engineering customized nanovaccines for enhanced cancer immunotherapy
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 13
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 13
Self‐Carrier Nanoparticles for Delivery of Paclitaxel and IDO Inhibitor to Boost Antitumor Chemo‐Immunotherapy
Zixuan Li, Qing Pei, Min Zhao, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 30
Closed Access | Times Cited: 12
Zixuan Li, Qing Pei, Min Zhao, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 30
Closed Access | Times Cited: 12
Self-adjuvanting cancer nanovaccines
Zhiyun Liao, Jing Huang, Pui‐Chi Lo, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Zhiyun Liao, Jing Huang, Pui‐Chi Lo, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Carbon Dots and Tumor Antigen Conjugates as Nanovaccines for Elevated Cancer Immunotherapy
Hongxin Liu, Zhigang Xie, Min Zheng
Small (2023) Vol. 19, Iss. 31
Closed Access | Times Cited: 21
Hongxin Liu, Zhigang Xie, Min Zheng
Small (2023) Vol. 19, Iss. 31
Closed Access | Times Cited: 21
Nano-Drug Delivery Systems in Oral Cancer Therapy: Recent Developments and Prospective
Yun Zhang, Yongjia Wu, Hongjiang Du, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 7-7
Open Access | Times Cited: 20
Yun Zhang, Yongjia Wu, Hongjiang Du, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 7-7
Open Access | Times Cited: 20
Global trends in tumor microenvironment-related research on tumor vaccine: a review and bibliometric analysis
Ying Liu, Sixin Li, Lu Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Ying Liu, Sixin Li, Lu Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress
Shigao Cheng, Huiyuan Wang, Xuejia Kang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 251-251
Open Access | Times Cited: 7
Shigao Cheng, Huiyuan Wang, Xuejia Kang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 251-251
Open Access | Times Cited: 7
Targeting tumor-associated macrophages with mannosylated nanotherapeutics delivering TLR7/8 agonist enhances cancer immunotherapy
Bao-Toan Nguyen Dang, Ramesh Duwa, Sooyeun Lee, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 587-608
Closed Access | Times Cited: 7
Bao-Toan Nguyen Dang, Ramesh Duwa, Sooyeun Lee, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 587-608
Closed Access | Times Cited: 7
Molecular Engineering of Electrosprayed Hydrogel Microspheres to Achieve Synergistic Anti‐Tumor Chemo‐Immunotherapy with ACEA Cargo
Youming Deng, Jiayang Li, Ran Tao, et al.
Advanced Science (2024) Vol. 11, Iss. 17
Open Access | Times Cited: 6
Youming Deng, Jiayang Li, Ran Tao, et al.
Advanced Science (2024) Vol. 11, Iss. 17
Open Access | Times Cited: 6
Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies
Hang Liang, Min Cui, Jingyao Tu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6
Hang Liang, Min Cui, Jingyao Tu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6
Development of functional nanomedicines for tumor associated macrophages-focused cancer immunotherapy
Wei Xiao, Jing Wang, Min Liang, et al.
Theranostics (2022) Vol. 12, Iss. 18, pp. 7821-7852
Open Access | Times Cited: 26
Wei Xiao, Jing Wang, Min Liang, et al.
Theranostics (2022) Vol. 12, Iss. 18, pp. 7821-7852
Open Access | Times Cited: 26
Recent Advances in Nanoparticles-Based Platforms Targeting the PD-1/PD-L1 Pathway for Cancer Treatment
Xin Yu, Chao Fang, Kun Zhang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1581-1581
Open Access | Times Cited: 24
Xin Yu, Chao Fang, Kun Zhang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1581-1581
Open Access | Times Cited: 24
Advances in nanomaterials for the diagnosis and treatment of head and neck cancers: A review
Cheng Yu, Long Li, Shiwen Wang, et al.
Bioactive Materials (2022) Vol. 25, pp. 430-444
Open Access | Times Cited: 23
Cheng Yu, Long Li, Shiwen Wang, et al.
Bioactive Materials (2022) Vol. 25, pp. 430-444
Open Access | Times Cited: 23
Detachable MOF‐Based Core/Shell Nanoreactor for Cancer Dual‐Starvation Therapy With Reversing Glucose and Glutamine Metabolisms
DU Hui-ping, Siyu Meng, Meijuan Geng, et al.
Small (2023) Vol. 19, Iss. 42
Closed Access | Times Cited: 16
DU Hui-ping, Siyu Meng, Meijuan Geng, et al.
Small (2023) Vol. 19, Iss. 42
Closed Access | Times Cited: 16
Overcoming Suppressive Tumor Microenvironment by Vaccines in Solid Tumor
Ya‐Jia Xie, Wen-Qian Liu, Dan Li, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 394-394
Open Access | Times Cited: 14
Ya‐Jia Xie, Wen-Qian Liu, Dan Li, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 394-394
Open Access | Times Cited: 14
Efficient TNBC immunotherapy by dual reprogramming tumor-infiltrating dendritic cells and tumor-associated macrophages with stimulus-responsive miR155 nanocomplexes
Zhenghui Jing, Yanfeng Li, Jinxiao Song, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126912-126912
Closed Access | Times Cited: 12
Zhenghui Jing, Yanfeng Li, Jinxiao Song, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126912-126912
Closed Access | Times Cited: 12
Recent Progress in Cancer Vaccines and Nanovaccines
Kishwor Poudel, Tulasi Vithiananthan, Jong Oh Kim, et al.
Biomaterials (2024) Vol. 314, pp. 122856-122856
Closed Access | Times Cited: 4
Kishwor Poudel, Tulasi Vithiananthan, Jong Oh Kim, et al.
Biomaterials (2024) Vol. 314, pp. 122856-122856
Closed Access | Times Cited: 4
Effective design of therapeutic nanovaccines based on tumor neoantigens
Weilin Wang, Yujia Zhai, Xiaoye Yang, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 17-35
Closed Access
Weilin Wang, Yujia Zhai, Xiaoye Yang, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 17-35
Closed Access